Highest-materiality recent filing
SunOpta completes acquisition by Refresco affiliate for $6.50/share, going private
SunOpta acquired by Refresco affiliate for US$6.50 per Common Share in cash.
SunOpta shareholders approve $6.50/share acquisition by Refresco
98.06% of votes cast approved the acquisition by Refresco at US$6.50 per share.
SunOpta to be acquired by Pegasus BidCo for $6.50/share cash; deal expected Q2 2026
Consideration of $6.50 per common share in cash; total equity value not disclosed.
SunOpta raises FY2025 revenue outlook to $816-818M and Adj. EBITDA to $94-95M
Revenue outlook raised from $812-816M to $816-818M (~13% YoY growth).
SunOpta Q3 revenue +16.8% to $205.4M; cuts FY adj. EBITDA guidance to $90-92M
Revenue $205.4M (+16.8% YoY) on volume growth across beverages, broths, and fruit snacks.
SunOpta Q2 revenue +13% to $191.5M; adj. EBITDA +14%; reaffirms FY2025 outlook
Revenue $191.5M (+12.9% YoY) driven by 14.4% volume growth; adjusted EBITDA $22.7M (+13.9%).
SunOpta Q1 revenue up 9.3% to $202M; raises FY2025 outlook; authorizes $25M buyback
Revenue $201.6M (+9.3% YoY); volume growth 12.2% drives top line.
Revenue from continuing operations increased 8.9% to $193.9 million, driven by 12.8% volume growth.
SunOpta Q3 revenue up 15.5% to $176.2M; adjusted EBITDA up 12.6% to $21.5M; reaffirms FY outlook
Revenue $176.2M (+15.5% YoY) driven by 20.6% volume growth partially offset by 2.8% price reduction on pass-through commodity costs.
SunOpta Q2 rev up 21% to $171M; loss narrows to $3.8M; raises 2024 revenue guidance
Revenue $171M up 21% YoY driven by 26.9% volume growth; price reduction of 3.9% on pass-through commodities.
SunOpta Q1 rev $182.8M (+18%), EPS $0.03; raises FY2024 outlook
Revenue $182.8M, up 18% YoY from $155.0M, driven by 23.5% volume growth.
SunOpta Q4 revenue up 13.7% to $181.6M; Adj. EBITDA +17.5%; reaffirms 2024 outlook
Q4 revenue $181.6M, +13.7% YoY on 14.7% volume/mix growth; price -1.0%.
SunOpta enters new $265M credit facilities, repays existing debt
New $180M term loan and $85M revolver, with $210M drawn at closing, used to fully repay 2020 credit facility and capital leases.
SunOpta CEO Joe Ennen to retire; Brian Kocher appointed effective Jan 2, 2024
Ennen to retire as CEO and director on Jan 2, 2024; will serve as advisor through Apr 1, 2024.
SunOpta Q3 revenue up 5.9% to $152.5M; loss from continuing ops of $5.7M vs prior year profit
Revenue $152.5M, up 5.9% YoY on 5.5% volume growth; adjusted EBITDA $19.1M, up 8.1% from $17.7M.
Sale price $141M includes $20M seller promissory notes; closed Oct 12, 2023.
Sold frozen fruit assets to Nature's Touch for $141M (incl. $20M seller notes); net proceeds to reduce debt.
SunOpta Q2 net loss $18.8M, oat milk revenue up 59%; revises FY2023 outlook lower
Revenue $207.8M (-6.5% adj. for sunflower); net loss $18.8M vs prior year net income $1.5M, includes $8.8M tax valuation allowance and $2.5M frozen fruit recall cost.
SunOpta Q1 Adj EBITDA up 50.5% to $23.6M; reaffirms FY2023 outlook
Revenue ex-sunflower $223.9M (+0.4%); plant-based milk sales up 25% YoY.
SunOpta Q4 revenue up 8.4% to $221.3M; Adj. EBITDA $23.5M (+122.7%); reaffirms FY2023 outlook
Q4 revenue $221.3M (+8.4% YoY); plant-based segment up 23.5% ex-sunflower; gross profit +56.4% to $28.2M.
SunOpta Q3 revenue rises 15.7% to $229.7M; adjusted EBITDA up 41.7%, raises FY2022 outlook
Revenue $229.7M (+15.7% YoY); plant-based +19.9%, fruit-based +10.0%.
SunOpta Q2 revenue up 20.4% to $243.5M; raises FY2022 guidance
Revenue $243.5M (+20.4% YoY); plant-based $145.9M (+31.0%), fruit-based $97.6M (+7.4%).
SunOpta Q4 revenue flat at $204.2M, gross margin collapses to 9.0%; guides FY22 EBITDA $67-75M
Q4 revenue $204.2M, down 0.6% YoY; plant-based +5.8%, fruit-based -9.4%.
SunOpta Q3 fiscal 2021 revenue up 3.6%; plant-based up 16%; adjusted EBITDA up 8.4%
Revenue $198.5M (+3.6% YoY); plant-based segment $114.9M (+16%), fruit-based $83.6M (-9.7%).
SunOpta subsidiary leases $50M equipment for new Texas plant-based beverage facility
Two equipment leases (Lease 4: $20M, Lease 7: $30M) with Liberty Commercial Finance LLC.
SunOpta signs 15-year lease for new plant-based beverage facility near Dallas-Fort Worth
Lease for 284,495 sq ft facility in Ellis County, TX; initial term 15 years plus three 5-year renewal options.
SunOpta Q2 revenue up 9.7% to $202.3M; adjusted EBITDA up 60.8% to $16.1M
Revenue $202.3M (+9.7% YoY); plant-based up 21.4% to $111.4M, fruit-based down 1.9% to $90.9M.
Steven Wood Presley, William Lewis McFarland II, Alan Humes and Stephane Bellemare were appointed as the directors of the Company, effective as of the Effective Time.
each of Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company’s board of directors, and any committee thereof, effective as of the Effective Time.
each of Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company’s board of directors, and any committee thereof, effective as of the Effective Time.
Steven Wood Presley, William Lewis McFarland II, Alan Humes and Stephane Bellemare were appointed as the directors of the Company, effective as of the Effective Time.
each of Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company’s board of directors, and any committee thereof, effective as of the Effective Time.
each of Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company’s board of directors, and any committee thereof, effective as of the Effective Time.
each of Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company’s board of directors, and any committee thereof, effective as of the Effective Time.
Steven Wood Presley, William Lewis McFarland II, Alan Humes and Stephane Bellemare were appointed as the directors of the Company, effective as of the Effective Time.
each of Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company’s board of directors, and any committee thereof, effective as of the Effective Time.
each of Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company’s board of directors, and any committee thereof, effective as of the Effective Time.
Steven Wood Presley, William Lewis McFarland II, Alan Humes and Stephane Bellemare were appointed as the directors of the Company, effective as of the Effective Time.
On September 13, 2024, Katrina Houde, notified SunOpta, Inc. ("SunOpta" or the "Company"), that she intends to resign from her position as a member of the Company's Board of Directors effective September 16, 2024, in order to focus on other opportunities.
Max materiality 1.00 · Median 0.70 · Most common event earnings